Renaissance Technologies’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-178,300
| Closed | -$1.19M | – | 3885 |
|
|
2025
Q1 | $1.19M | Buy |
178,300
+49,257
| +38% | +$328K | ﹤0.01% | 2303 |
|
|
2024
Q4 | $1.42M | Buy |
+129,043
| New | +$1.42M | ﹤0.01% | 2284 |
|
|
2024
Q3 | – | Sell |
-11,200
| Closed | -$151K | – | 3873 |
|
|
2024
Q2 | $151K | Sell |
11,200
-7,900
| -41% | -$107K | ﹤0.01% | 3105 |
|
|
2024
Q1 | $258K | Buy |
+19,100
| New | +$258K | ﹤0.01% | 3140 |
|
|
2023
Q3 | – | Sell |
-42,300
| Closed | -$450K | – | 4094 |
|
|
2023
Q2 | $450K | Sell |
42,300
-23,400
| -36% | -$249K | ﹤0.01% | 2930 |
|
|
2023
Q1 | $547K | Sell |
65,700
-38,900
| -37% | -$324K | ﹤0.01% | 2837 |
|
|
2022
Q4 | $965K | Sell |
104,600
-22,200
| -18% | -$205K | ﹤0.01% | 2553 |
|
|
2022
Q3 | $1.63M | Sell |
126,800
-27,100
| -18% | -$348K | ﹤0.01% | 2163 |
|
|
2022
Q2 | $2.03M | Buy |
153,900
+141,800
| +1,172% | +$1.87M | ﹤0.01% | 2183 |
|
|
2022
Q1 | $255K | Buy |
+12,100
| New | +$255K | ﹤0.01% | 3542 |
|
|
2021
Q4 | – | Sell |
-82,800
| Closed | -$2.11M | – | 4214 |
|
|
2021
Q3 | $2.11M | Buy |
82,800
+1,500
| +2% | +$38.2K | ﹤0.01% | 2046 |
|
|
2021
Q2 | $2.74M | Buy |
81,300
+29,100
| +56% | +$980K | ﹤0.01% | 2033 |
|
|
2021
Q1 | $2.03M | Buy |
+52,200
| New | +$2.03M | ﹤0.01% | 2216 |
|